Skip to main content

Advertisement

Table 2 Baseline characteristics of two groups in immunologic response

From: Feasibility study of DCs/CIKs combined with thoracic radiotherapy for patients with locally advanced or metastatic non-small-cell lung cancer

Characteristics Treatment group Control group P value
Number 21 20  
Age (years)    
 Mean (Range) 56.6 (32–74) 54.3 (39–68) 0.48
Gender    
 Male 19 (90.5 %) 17 (85 %)  
 Female 2 (9.5 %) 3 (15 %) 0.66
Clinical stage    
 III 10 (47.6 %) 10 (50 %)  
 IV 11 (52.4 %) 10 (50 %) 0.88
Tumor histology    
 Adenocarcinoma 8 (38.1 %) 10 (50 %)  
 Squamous carcinoma 13 (61.9 %) 10 (50 %) 0.44
Cycles of previous chemotherapy 2.9 ± 0.7 2.4 ± 0.5 0.06
PS score 0.4 ± 0.6 0.5 ± 0.6 0.91